The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
MicroRNAs 103 and 107 regulate insulin sensitivity
Open accessAbstract
Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes. MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism. However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MicroRNA inhibitors (antagomirs) targeting miR-103 and miR-107 improve insulin sensitivity and reduce adiposity in diet-induced obese mice by enhancing hepatic and peripheral insulin signaling [92].”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citationCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,259
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,456
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E. R., Hanson, E. M., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,023
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 996
MicroRNA as therapeutic targets for treatment of depression
Obrietan, K. H., & Hansen, K. F. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s34811 · Cited by 55
Khalyfa, A., Mutskov, V. J., Carreras, A., Khalyfa, A. A., Hakim, F., & Gozal, D. (2014) · Diabetes · doi:10.2337/db14-0202 · Cited by 53
Novel approaches to restore beta cell function in prediabetes and type 2 diabetes
Salunkhe, V. A., Veluthakal, R., Kahn, S. E., & Thurmond, D. C. (2018) · Diabetologia · doi:10.1007/s00125-018-4658-3 · Cited by 63
Meta-Analysis of Differential miRNA Expression after Bariatric Surgery
Langi, G., Szczerbiński, Ł., & Kretowski, A. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081220 · Cited by 54
Herzer, S., Silahtaroglu, A., & Meister, B. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02358.x · Cited by 54
Lie, S., Morrison, J. L., Williams-Wyss, O., Suter, C. M., Humphreys, D. T., Ozanne, S. E., Zhang, S., MacLaughlin, S. M., Kleemann, D. O., Walker, S. K., et al. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.109751 · Cited by 52
Emerging Role of mTOR Signaling‐Related miRNAs in Cardiovascular Diseases
Samidurai, A., Kukreja, R. C., & Das, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6141902 · Cited by 51
Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets
Tugay, K., Guay, C., Marques, A. C., Allagnat, F., Locke, J. M., Harries, L. W., Rutter, G. A., & Regazzi, R. (2015) · Diabetologia · doi:10.1007/s00125-015-3783-5 · Cited by 51
Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease
Soronen, J., Yki‐Järvinen, H., Zhou, Y., Sädevirta, S., Sarin, A., Leivonen, M., Sevastianova, K., Perttilä, J., Laurila, P., Sigrüener, A., et al. (2016) · Physiological Reports · doi:10.14814/phy2.12661 · Cited by 52
miR-107 inhibits CDK6 expression, differentiation, and lipid storage in human adipocytes
Ahonen, M. A., Haridas, P. A. N., Mysore, R., Wabitsch, M., Fischer‐Posovszky, P., & Olkkonen, V. M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.09.007 · Cited by 51
The Emerging Role and Promise of Circular RNAs in Obesity and Related Metabolic Disorders
Zaiou, M. (2020) · Cells · doi:10.3390/cells9061473 · Cited by 50
Dávalos, A., & Fernandez-Hernando, C. F. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.02.005 · Cited by 52
A Dicer-miR-107 Interaction Regulates Biogenesis of Specific miRNAs Crucial for Neurogenesis
Ristori, E., Lopez‐Ramirez, M. A., Narayanan, A., Hill-Terán, G., Moro, A., Calvo, C., Thomas, J., & Nicoli, S. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.12.013 · Cited by 54
LXR is a negative regulator of glucose uptake in human adipocytes
Pettersson, A., Stenson, B. M., Lorente‐Cebrián, S., Andersson, D. P., Mejhert, N., Krätzel, J., Åström, G., Dahlman, I. A., Chibalin, A., Arner, P., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2954-5 · Cited by 50
Berezin, A. Е., & Berezin, A. A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00047 · Cited by 51
Mantilla-Escalante, D. C., Hazas, M. L. D. L., Crespo, M. C., Martín‐Hernández, R., Tomé‐Carneiro, J., del Pozo‐Acebo, L., Salas‐Salvadó, J., Bulló, M., & Dávalos, A. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02594-0 · Cited by 51
miRNAs as Biomarkers in Diabetes: Moving towards Precision Medicine
Angelescu, M. A., Andronic, O., Dima, S., Popescu, I., Meivar‐Levy, I., Ferber, S., & Lixandru, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112843 · Cited by 51
Ghanbari, M., de Vries, P. S., de Looper, H. W. J., Peters, M. J., Schurmann, C., Yaghootkar, H., Dörr, M., Frayling, T. M., Uitterlinden, A. G., Albert Hofman, D., et al. (2014) · Human Mutation · doi:10.1002/humu.22706 · Cited by 48
Vailati-Riboni, M., Kanwal, M., Bulgari, O., Meier, S., Priest, N. V., Burke, C. R., Kay, J. K., McDougall, S., Mitchell, M. D., Walker, C. G., et al. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-10046 · Cited by 53
Bi, D., Du, J., Hu, R., Wang, A., Wu, W., Hu, C.-P., Li, Y., & Li, X. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.043 · Cited by 49
Boothe, T., Lim, G. E., Cen, H. H., Skovsø, S., Piske, M., Li, S. N., Nabi, I. R., Gilon, P., & Johnson, J. D. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.009 · Cited by 49
MicroRNA-103 promotes tumor growth and metastasis in colorectal cancer by directly targeting LATS2
Zheng, Y., Xiao, K., Xiao, G.-C., Tong, S., Ding, Y., Wang, Q., Li, S., & Hao, Z.-N. (2016) · Oncology Letters · doi:10.3892/ol.2016.4814 · Cited by 49
Pahlavani, M., Ramalho, T. R. D. O., Koboziev, I., LeMieux, M. J., Jayarathne, S., Ramalingam, L., Filgueiras, L. R., & Moustaïd‐Moussa, N. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000535 · Cited by 53
Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA
Sidorkiewicz, I., Jóźwik, M., Niemira, M., & Kretowski, A. J. (2020) · Cancers · doi:10.3390/cancers12092559 · Cited by 51
Integrative Analysis of Porcine microRNAome during Skeletal Muscle Development
Qin, L., Chen, Y., Liu, X., Ye, S., Yu, K., Huang, Z., Yu, J., Zhou, X., Chen, H., & Mo, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072418 · Cited by 47
Fisetin protects against hepatosteatosis in mice by inhibiting miR-378
Jeon, T., Park, J. W., Ahn, J., Jung, C. H., & Ha, T. Y. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300071 · Cited by 47
MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer
Fu, X., Zhang, W., Su, Y., Lu, L., Wang, D., & Wang, H. (2016) · The Prostate · doi:10.1002/pros.23143 · Cited by 48
Fang, W., Guo, J., Cao, Y., Wang, S., Pang, C., Li, M., Dou, L., Man, Y., Huang, X., Shen, T., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12835 · Cited by 49
NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging
Micó, V., Berninches, L., Tapia, J., & Daimiel, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050915 · Cited by 50
Early-life nutrition and metabolic disorders in later life: a new perspective on energy metabolism
Zhou, L., Deng, M., Zhang, Q., & Xiao, X.-H. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000976 · Cited by 53
MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes
Dou, L., Meng, X., Sui, X., Wang, S., Shen, T., Huang, X., Guo, J., Fang, W., Man, Y., Xi, J., et al. (2015) · Scientific Reports · doi:10.1038/srep11602 · Cited by 47
Ponsuksili, S., Du, Y., Hadlich, F., Siengdee, P., Muráni, E., Schwerin, M., & Wimmers, K. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-533 · Cited by 48
Caveolae: molecular insights and therapeutic targets for stroke
Xu, L., Guo, R., Xie, Y., Ma, M., Ye, R., & Liu, X. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1009446 · Cited by 47
Biological roles of microRNAs in the control of insulin secretion and action
Caldérari, S., Diawara, M. R., Garaud, A., & Gauguier, D. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00079.2016 · Cited by 50
Green, C. D., Huang, Y., Dou, X., Liu, Y., Liu, Y., & Han, J. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.001 · Cited by 48
Baik, M., Kang, H. J., Park, S., Na, S. W., Piao, M. Y., Kim, S. Y., Fassah, D. M., & Moon, Y. S. (2017) · Journal of Animal Science · doi:10.2527/jas.2016.1160 · Cited by 52
Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression
Brun, J., Berthou, F., Trajkovski, M., Maechler, P., Foti, M., & Bonnet, N. (2017) · Diabetes · doi:10.2337/db17-0116 · Cited by 47
Self-citationInsight into miRNAs related with glucometabolic disorder
Zhang, B., Shen, C., Zhu, B.-W., An, H., Zheng, B. J., Xu, S., Sun, J., Sun, P.-C., Zhang, W., Wang, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.123 · Cited by 48
Dou, L., Wang, S., Sun, L., Huang, X., Zhang, Y., Shen, T., Guo, J., Man, Y., Tang, W., & Li, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475912 · Cited by 46
MiR-29 family members interact with SPARC to regulate glucose metabolism
Song, H., Ding, L., Zhang, S., & Wang, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.129 · Cited by 46
MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease
Dai, L., Li, S., Ma, Y., Tang, J., Lv, J., Zhang, Y., Miao, Y., Ma, Y., Li, C., Chu, Y., et al. (2019) · Liver International · doi:10.1111/liv.14067 · Cited by 46
Huang, Z., Chen, Y., Guo, H., & Chen, G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.630876 · Cited by 49
Mitochondria homeostasis: Biology and involvement in hepatic steatosis to NASH
Li, Y., Xie, Z., Song, Q., & Li, J.-Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00864-z · Cited by 49
Zhao, Z. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.824 · Cited by 44
NUCKS Is a Positive Transcriptional Regulator of Insulin Signaling
Qiu, B., Shi, X., Wong, E. T., Lim, J., Bezzi, M., Low, D., Zhou, Q., Akıncılar, S. C., Lakshmanan, M., Swa, H. L. F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.030 · Cited by 45
MiR-15a/b promote adipogenesis in porcine pre-adipocyte via repressing FoxO1
Dong, P., Mai, Y., Zhang, Z., Mi, L., Wu, G., Chu, G., Yang, G., & Sun, S. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu043 · Cited by 47
HDL and microRNA therapeutics in cardiovascular disease
Michell, D. L., & Vickers, K. C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.001 · Cited by 45
Claudio Napoli, A., Schiano, C., & Soricelli, A. (2019) · Biochimie · doi:10.1016/j.biochi.2019.06.014 · Cited by 49
Mani, S. K. K., Yan, B., Cui, Z., Sun, J., Utturkar, S. M., Foca, A., Farés, N., Durantel, D., Lanman, N. A., Merle, P., et al. (2020) · Theranostics · doi:10.7150/thno.49629 · Cited by 46
Wu, C., Biggar, K. K., & Storey, K. B. (2014) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2014.08.003 · Cited by 44
The role of microRNA in nutritional control
Hoen, E. N. M. N., van Rooij, E., Bushell, M., Zhang, C. ‐., Dashwood, R. H., James, W. P. T., Harris, C. C., & Baltimore, D. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12372 · Cited by 45
Seyhan, A. A. (2015) · Molecular BioSystems · doi:10.1039/c5mb00064e · Cited by 43
Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes
Luo, M., Li, R., Deng, X., Ren, M., Ni, C., Zeng, M., Yan, K., Xia, J., Liu, F., Ma, W., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0733-0 · Cited by 44
Caveolins: targeting pro-survival signaling in the heart and brain
Stary, C. M., Tsutsumi, Y. M., Patel, P. M., Head, B. P., Patel, H. H., & Roth, D. M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00393 · Cited by 46
Small but smart: MicroRNAs orchestrate atherosclerosis development and progression
Santovito, D., Egea, V., & Weber, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.12.013 · Cited by 45
The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases
Sethupathy, P. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0745-3 · Cited by 44
MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1
Luo, A., Yan, H., Liang, J., Du, C., Zhao, X., Sun, L., & Chen, Y. (2017) · Gene · doi:10.1016/j.gene.2017.06.024 · Cited by 44
Zheng, P., Bin, H., & Chen, W. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0821-2 · Cited by 43
Hung, Y.-H., Kanke, M., Kurtz, C. L., Cubitt, R. L., Bunaciu, R. P., Miao, J., Zhou, L., Graham, J. L., Hussain, M. M., Havel, P. J., et al. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00037.2019 · Cited by 46
miR-146a regulates insulin sensitivity via NPR3
Roos, J., Dahlhaus, M., Funcke, J., Kustermann, M., Strauß, G., Halbgebauer, D., Boldrin, E., Holzmann, K., Möller, P., Trojanowski, B. M., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03699-1 · Cited by 46
Bazrgar, M., Khodabakhsh, P., Prudencio, M., Mohagheghi, F., & Ahmadiani, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105805 · Cited by 45
Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells
Mohan, R., Mao, Y., Zhang, S., Zhang, Y.-W., Xu, C., Gradwohl, G., & Tang, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650705 · Cited by 44
The miR‐181 family: Wide‐ranging pathophysiological effects on cell fate and function
Bell‐Hensley, A., Das, S., & McAlinden, A. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30969 · Cited by 44
miR-144/451 Promote Cell Proliferation via Targeting PTEN/AKT Pathway in Insulinomas
Jiang, X., Shan, A., Su, Y., Cheng, Y., Gu, W., Wang, W., Ning, G., & Cao, Y. (2015) · Endocrinology · doi:10.1210/en.2014-1966 · Cited by 43
Lu, Z., Xu, J., Xu, M., Pasternak, G. W., & Pan, Y. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089292 · Cited by 43
Zhang, C., Seo, J., Murakami, K., Salem, E., Bernhard, E., Borra, V. J., Choi, K., Yuan, C. L., Chan, C. C., Chen, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05870-6 · Cited by 42
MicroRNAs and their delivery in diabetic fibrosis
Wonnacott, A., Denby, L., Coward, R. J., Fraser, D. J., & Bowen, T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114045 · Cited by 44
Regulation of cholesterol biosynthesis and lipid metabolism: A microRNA management perspective
Bhattarai, A., Likos, E., Weyman, C. M., & Shukla, G. C. (2021) · Steroids · doi:10.1016/j.steroids.2021.108878 · Cited by 44
Yu, J., Kong, X., Liu, J., Lv, Y., Sheng, Y., Lv, S., Di, W., Wang, C., Zhang, F., & Ding, G. (2014) · Endocrinology · doi:10.1210/en.2013-2105 · Cited by 43
Analysis of Plasma microRNA Associated with Hemolysis
Shkurnikov, M. Y., Knyazev, E. N., Фомичева, К. А., Mikhaylenko, D. S., Nyushko, K. М., Saribekyan, E. K., Samatov, T. R., & Alekseev, B. Y. (2016) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-016-3300-y · Cited by 42
Identification of microRNA that represses IRS-1 expression in liver
Ono, K., Igata, M., Kondo, T., Kitano, S., Takaki, Y., Hanatani, S., Sakaguchi, M., Goto, R., Senokuchi, T., Kawashima, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191553 · Cited by 42
MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1
Zhang, M., Tang, Y., Tang, E., & Lu, W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.143 · Cited by 42
Transcriptional Perturbations in Graft Rejection
Vitalone, M. J., Sigdel, T. K., Salomonis, N., Sarwal, R. D., Hsieh, S., & Sarwal, M. (2015) · Transplantation · doi:10.1097/tp.0000000000000809 · Cited by 42
Galal, M. A., Alouch, S. S., Alsultan, B. S., Dahman, H., Alyabis, N. A., Alammar, S., & Aljada, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915006 · Cited by 45
Dong, J., Liang, Y., Zhang, J., Wu, L., Wang, S., Hua, Q., & Yan, Y.-X. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.35923 · Cited by 42
The number of titrated microRNA species dictates ceRNA regulation
Chiu, H., Martínez, M. R., Komissarova, E. V., Llobet‐Navàs, D., Bansal, M., Paull, E., Silva, J., Yang, X., Sumazin, P., & Califano, A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky286 · Cited by 41
Innovative approaches in transforming microRNAs into therapeutic tools
Samad, A. F. A., & Kamaroddin, M. F. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1768 · Cited by 42
Endocrine disrupting chemicals: gestational diabetes and beyond
Mitra, T., Gulati, R., Ramachandran, K., Rajiv, R., Enninga, E. A. L., Pierret, C. K., Sajeetha Kumari, R., & Janardhanan, R. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01317-9 · Cited by 41
Insulin Resistance Associated Genes and miRNAs
Honardoost, M., Sarookhani, M. R., Arefian, E., & Soleimani, M. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1014-z · Cited by 40
Implications of microRNAs in the pathogenesis of diabetes
Park, S., Jeong, H.-J., Yang, W., & Lee, W. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0017-6 · Cited by 41
Serafin, A., Foco, L., Blankenburg, H., Picard, A., Zanigni, S., Zanon, A., Pramstaller, P. P., Hicks, A. A., & Schwienbacher, C. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-715 · Cited by 40
Xu, M., Zheng, X., Jiang, F., & Qiu, W. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26776 · Cited by 40
Arancio, W., Amato, M. C., Magliozzo, M., Pizzolanti, G., Vesco, R., & Giordano, C. S. D. S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1428299 · Cited by 44
Liu, K., Hao, Q., Wei, J., Li, G.-H., Wu, Y., & Zhao, Y.-F. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001769 · Cited by 40
Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice
Jiang, X., Jiang, L., Shan, A., Su, Y., Cheng, Y., Song, D., Ji, H., Ning, G., Wang, W., & Cao, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.051 · Cited by 40
Right ventricular dysfunction and remodeling in diabetic cardiomyopathy
Kang, Y., Wang, S., Huang, J., Cai, L., & Keller, B. B. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00440.2018 · Cited by 40
AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism
Rech, M., Kuhn, A.-R., Lumens, J., Carai, P., van Leeuwen, R. E. W., Verhesen, W., Verjans, R., Lecomte, J., Liu, Y., Luiken, J. J. F. P., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.12.010 · Cited by 40
Li, Q., Hu, S., Wang, Y., Deng, Y., Yang, S., Hu, J., Li, L., & Wang, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00988 · Cited by 40
Bhatia, H., PATTNAIK, B. R., & Datta, M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.225 · Cited by 41
Alamro, H., Bajić, V., Mačvanin, M., Isenović, E. R., Gojobori, T., Essack, M., & Gao, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1084656 · Cited by 43
Epigenetics in autoimmune diseases: Unraveling the hidden regulators of immune dysregulation
Bagni, G., Biancalana, E., Chiara, E., Costanzo, I., Malandrino, D., Lastraioli, E., Palmerini, M., Silvestri, E., Urban, M. L., & Emmi, G. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103784 · Cited by 39
MiR-378 Plays an Important Role in the Differentiation of Bovine Preadipocytes
Liu, S., Zhang, Y., Gao, Y., Zhang, L., Chen, H., Zhou, Q., Chai, M.-L., Li, Q.-Y., Jiang, H., Yuan, B., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430318 · Cited by 40
Jeong, B., Kang, I., & Koh, J. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.07.035 · Cited by 39
Integrating miRNA and mRNA Expression Profiling Uncovers miRNAs Underlying Fat Deposition in Sheep
Zhou, G., Wang, X., Yuan, C., Kang, D., Xu, X., Zhou, J., Geng, R., Yang, Y., Yang, Z., & Chen, Y. (2017) · BioMed Research International · doi:10.1155/2017/1857580 · Cited by 39
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?
Beck, R., Stýblo, M., & Sethupathy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0845-8 · Cited by 39
MiRNA Deregulation in Cardiac Aging and Associated Disorders
Verjans, R., van Bilsen, M., & Schroen, B. L. M. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.004 · Cited by 39
Croizier, S., Park, S., Maillard, J., & Bouret, S. G. (2018) · eLife · doi:10.7554/elife.40429 · Cited by 39
Yang, L., Zhang, B., Wang, X., Liu, Z., Li, J., Zhang, S., Gu, X., Jia, M., Guo, H.-T., Feng, N., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15053 · Cited by 38
Zhang, G., Yang, Y., Hu, H., Liu, K., Li, B., Zhu, Y., Wang, Z., Wu, Q., & Mei, Y. (2021) · Oncogene · doi:10.1038/s41388-021-01749-x · Cited by 36
Bacon, S., Engelbrecht, B., Schmid, J., Pfeiffer, S., Gallagher, R., McCarthy, A., Burke, M., Concannon, C. G., Prehn, J. H. M., & Byrne, M. M. (2015) · Genes · doi:10.3390/genes6020399 · Cited by 41
Metadata
- Authors
- Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- University of Basel (CH)
- Regulus Therapeutics (United States) (US)
- University Hospital of Basel (CH)
- Corresponding author
- Stoffel, Markus
- Venue
- Nature
- Published
- 2011-06
- Volume
- 474
- Issue
- 7353
- Pages
- 649-653
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075317528
- Cited by
- 1,000
- References
- 27
- Citations by year
- 2026: 36 · 2025: 34 · 2024: 54 · 2023: 45 · 2022: 61 · 2021: 61 · 2020: 71 · 2019: 68 · 2018: 80 · 2017: 65 · 2016: 98 · 2015: 90 · 2014: 90 · 2013: 77 · 2012: 57
- FWCI
- 25.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Juvenile Diabetes Research Foundation International
- Fondation Leducq
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- microRNA-107, insulin sensitivity, caveolin-1, insulin signaling, insulin receptor, glucose homeostasis, obesity, type 2 diabetes, adipocytes, liver, insulin-stimulated glucose uptake, adipocyte size, miRNA target genes
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Glucose, Homeostasis, Hyperglycemia, Insulin, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Up-Regulation, Gene Expression, Adipocytes, Gene Silencing, MicroRNAs, Cell Size, Caveolin 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review